Treatment-related and health-related quality of life in lipoprotein apheresis patients

Véronique De Gucht(Leiden University), Stan Maes(Vrije Universiteit Brussel), Anja Vogt(LMU Klinikum), Krister Cromm(Humboldt-Universität zu Berlin), Ulrich Julius(Technische Universität Dresden), Ralf Spitthöver(PHV Dialysezentrum), Volker Schettler(Nephrologisches Zentrum Goettingen), Bernd Hohenstein(Technische Universität Dresden), Wolfgang Ramlow(Rostocker Zentrum zur Erforschung des Demografischen Wandels)
Journal of clinical lipidology
May 26, 2018
10.1016/j.jacl.2018.05.008
Cited by 15

Related Papers

Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure
|New England Journal of Medicine|2023|287
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
|BMJ Open|2020|67
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration
|Kidney International|2024|48
CONVINCE in the context of existing evidence on haemodiafiltration
|Nephrology Dialysis Transplantation|2022|28
A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis
|Kidney International|2025|17